Fig ACCF/AHA Guideline for the management of heart failure

Slides:



Advertisements
Similar presentations
Cardiovascular Disaster in Hemodialysis patients
Advertisements

Heart failure with preserved ejection fraction (HFpEF)
Diastolic Heart Failure, HFpEF, HFnEF: What are we treating anyway? Charles M. Rasmussen, MD FACC.
Heart Failure Management Focus on Primary Care Practice.
Heart Failure: Living with a Hurting Heart. Congestive Heart Failure Heart (or cardiac) failure is the state in which the heart is unable to pump blood.
Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Pharmacologic Treatment of Chronic Systolic Heart Failure John N. Hamaty D.O. FACC, FACOI.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
L References Application to Clinical Practice The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have cooperatively.
European Heart Journal 2010 European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic.
Subgroup Placebo n/N (%) Serelaxin n/N (%)Favours placeboFavours serelaxin Odds ratio Estimate (95%CI) Interaction P value Total population150/580 (25.9)156/581.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Treatment Times Through Formalized.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
To know more visit HeartFailure.com © 2016 Novartis Pharma AG, July 2016, GLCM/HTF/0028c HEART FAILURE DISEASE MANAGEMENT STANDARDS.
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure  Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA, Mariell.
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Management of mitral regurgitation. See legend for Fig
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
Copyright © 2015 by the American Osteopathic Association.
Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure  Justin A. Ezekowitz, MBBCh, Eileen O'Meara,
Chapter 8: Cardiovascular Disease in Patients with ESRD
Volume 1: Chronic Kidney Disease
Subclinical organ damage Treatment LVH
Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.
by Gregg C. Fonarow, Clyde W. Yancy, Nancy M. Albert, Anne B
Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,
Developed in Collaboration With The American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology,
Systolic Heart Failure: Medical Therapy
Diabetes Mellitus and Heart Failure
Clyde W. Yancy et al. JACC 2017;70:
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice  Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,
Joerg Herrmann, MD, Amir Lerman, MD, Nicole P
Figure 1 Energy supply–demand matching in health and heart failure
Chapter 4: Cardiovascular Disease in Patients with CKD
Nat. Rev. Cardiol. doi: /nrcardio
Can Vitamin D Deficiency Break Your Heart?
Step Care Therapy for Hypertension in Diabetic Patients
Obesity and Heart Failure: Focus on the Obesity Paradox
Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology,
Chapter 8: Cardiovascular Disease in Patients with ESRD
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Sexual Activity and Chronic Heart Failure
Quantitating the Dose of Physical Activity in Secondary Prevention: Relation of Exercise Intensity to Survival  Barry A. Franklin, PhD  Mayo Clinic Proceedings 
John E. Sanderson JCHF 2014;2:93-94
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
Fig. 2. Evidence-based medication prescriptions
Nat. Rev. Cardiol. doi: /nrcardio
Congestive Heart Failure
Atrial Fibrillation: Beyond Rate Control
Ethnic and racial disparities in cardiac resynchronization therapy
Schematic diagram showing as yet unexplored pathophysiological mechanisms in pulmonary arterial hypertension (PAH). Schematic diagram showing as yet unexplored.
Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S
Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.
Rami Doukky et al. JCHF 2016;4:24-35
Adjunctive Therapies in the Treatment of Acute Coronary Syndromes
Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),
Figure 3. Survival rates according to renal dysfunction
Lifetime heart failure risk*
Percentage distribution of ESC HF subtypes and no cardiac dysfunction (no dysf, n=38) among all 370 included patients, where HFvhd is HF due to valvular.
Rick A. Nishimura et al. JACC 2017;70:
Figure 8. Stroke prevention strategy in patients with AF
β-Blocker Use for the Stages of Heart Failure
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
Flow diagram of the recommended pharmacological management of heart failure adapted from the European Society of Cardiology guidelines Flow diagram.
Presentation transcript:

Fig. 2. 2013 ACCF/AHA Guideline for the management of heart failure Fig. 2. 2013 ACCF/AHA Guideline for the management of heart failure. HF: heart failure, ACEI: angiotensin-converting enzyme inhibitor, AF: atrial fibrillation, ARB: angiotensin-receptor blocker, CAD: coronary artery disease, CRT: cardiac resynchronization therapy, DM: diabetes mellitus, EF: ejection fraction, GDMT: guideline-directed medical therapy, HF: heart failure, HFpEF: heart failure with preserved ejection fraction, HFrEF: heart failure with reduced ejection fraction, HRQOL: health-related quality of life, HTN: hypertension, ICD: implantable cardioverter-defibrillator, LV: left ventricular, LVH: left ventricular hypertrophy, MCS: mechanical circulatory support, MI: myocardial infarction. Fig. 2. 2013 ACCF/AHA Guideline for the management of heart failure. HF: heart failure, ACEI: angiotensin-converting enzyme inhibitor, AF: atrial fibrillation, ARB: angiotensin-receptor blocker, CAD: coronary artery disease, CRT: cardiac resynchronization therapy, DM: diabetes mellitus, EF: ejection fraction, GDMT: guideline-directed medical therapy, HF: heart failure, HFpEF: . . . Korean Circ J. 2016 Sep;46(5):610-612. http://dx.doi.org/10.4070/kcj.2016.46.5.610

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.